Yang Jingchao, Yuan Longhui, Liu Fei, Li Lan, Liu Jingping, Chen Younan, Lu Yanrong, Yuan Yujia
Key Laboratory of Transplant Engineering and Immunology, NHC; Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Front Pharmacol. 2022 Aug 11;13:974829. doi: 10.3389/fphar.2022.974829. eCollection 2022.
Autophagy is a highly conserved cellular progress for the degradation of cytoplasmic contents including micromolecules, misfolded proteins, and damaged organelles that has recently captured attention in kidney diseases. Basal autophagy plays a pivotal role in maintaining cell survival and kidney homeostasis. Accordingly, dysregulation of autophagy has implicated in the pathologies of kidney diseases. In this review, we summarize the multifaceted role of autophagy in kidney aging, maladaptive repair, tubulointerstitial fibrosis and discuss autophagy-related drugs in kidney diseases. However, uncertainty still remains as to the precise mechanisms of autophagy in kidney diseases. Further research is needed to clarify the accurate molecular mechanism of autophagy in kidney diseases, which will facilitate the discovery of a promising strategy for the prevention and treatment of kidney diseases.
自噬是一种高度保守的细胞过程,用于降解包括小分子、错误折叠的蛋白质和受损细胞器在内的细胞质成分,最近在肾脏疾病中受到关注。基础自噬在维持细胞存活和肾脏内环境稳定方面起着关键作用。因此,自噬失调与肾脏疾病的病理过程有关。在本综述中,我们总结了自噬在肾脏衰老、适应性修复不良、肾小管间质纤维化中的多方面作用,并讨论了肾脏疾病中与自噬相关的药物。然而,关于自噬在肾脏疾病中的精确机制仍存在不确定性。需要进一步研究以阐明自噬在肾脏疾病中的准确分子机制,这将有助于发现预防和治疗肾脏疾病的有前景的策略。